NDUFA13 and movement disorder: Although families carrying the recurring NDUFA13 c.170G > A, p.(Arg57His) variant shared features such as infantile disease manifestation, slow disease progression rates, moderate-to-severe global global developmental delay and failure to acquire independent gait, there was a noticeable variation in the development of epileptic seizures, movement disorders and regression.